Navigation Links
Pieris in Medical News

Pieris Strengthens its Management, as it Prepares for the Clinical Development of PRS-050, an Anticalin(R)-Based Novel Cancer Therapy

...WEIHENSTEPHAN, Germany, November 8 /PRNewswire/ -- pieris AG, a biopharmaceutical company developing Antical...a Stern as Chief Operating Officer to the Company. pieris has also announced the promotion with immediate ef... Officer. The appointment of Dr Angelika Stern at pieris coincides with continued progress of the Company's...

Pieris and Pepscan to Identify GPCR-Specific Anticalins(R) Using CLIPS(TM) Protein Mimicry Technology

...WEIHENSTEPHAN, Germany, October 30 /PRNewswire/ -- pieris AG (Munich, Germany) and Pepscan Therapeutics (Lel... and their development as therapeutic candidates. pieris has pioneered Anticalins(R) as next generation tar...h therapeutic potential". Notes to editors About pieris AG ...
Pieris in Medical Technology

Wacker Validates Scalability of Anticalin(R) Production With E.coli Secretion Technology and Will Produce Pieris First Clinical Candidate PRS-050

FREISING-WEIHENSTEPHAN and JENA, Germany, July 17 /PRNewswire/ -- Pieris AG, a bio-pharmaceutical company developing Anticalins(R), a novel class of targeted human protein therapeutics, and Wacker Biotech GmbH, a full-service contract manufacturer of biopharmaceuticals, announced yesterday a s...

Pieris Reports Development Progress for Anticalin(R) PRS-050, a Next Generation VEGF Antagonist

...WEIHENSTEPHAN, Germany, February 3 /PRNewswire/ -- pieris AG, a biopharmaceutical company developing Antical...he mode of action of PRS-050 in vitro and in vivo, pieris has now validated the efficacy of the Anticalin(R)... Progress in the PRS-050 program demonstrates that pieris has fulfilled critical speed and capacity goals in...

Pieris Demonstrates Potent Anti-Tumor Activity of a VEGF-Specific Anticalin in Preclinical Studies

..., USA. "This example highlights perfectly how pieris is able to adapt pharmacokinetic properties of Ant...rable product profile." Notes to Editors About pieris AG pieris is a biopharmaceutical company engaged in the disc...

Pieris Progresses Development of its Proprietary Biotherapeutics Platform: Successful Demonstration of Dual Targeting With Duocalin(R) Technology

...Director of Science and Preclinical Development of pieris said: "As Pieris continues to validate the therape...nants on two defined clinically validated targets, pieris has constructed Duocalins(R) as monomeric, bivalen...y of the Anticalin(R) scaffold has already allowed pieris to develop therapeutic and diagnostic product cand...

Pieris Progresses Proprietary Asthma Program: Validation of Pulmonary Delivery of Anticalin-Based Protein Product Candidate

...tion via the lungs. PRS-060 has been selected by pieris as being specific for a target implicated in a mec...covery Technology Conference in Boston, MA, USA. pieris is now actively seeking development partners for t...in(R) and Duocalin(R) are registered trademarks of pieris AG. For further information, please contact:...
Pieris in Biological News

Secret of worm's poison pill box protein could produce new natural insecticide

... of a caterpillar’s gut called "Brush Border Membrane Vesicles" (BBMV). The XptA1 protein seemed to specifically target the BBMV of caterpillars pieris Brassicae ?(The cabbage white butterfly caterpillar which are pests for many growers). The hollow box structure appears to be a key element of the pr...
Pieris in Biological Technology

Pieris Raises EUR 25 M (US$ 38 M) in Series B Financing Round

...G-WEIHENSTEPHAN, Germany, March 27 /PRNewswire/ -- pieris AG, a bio-pharmaceutical company developing Antica... marks a significant milestone in the evolution of pieris as a product-focused biopharmaceutical company. Ha...nowned investors such as OrbiMed and Novo Nordisk, pieris is now in the position to deliver on its strategy ...

Pieris Validates the Use of Anticalins(R) as Ophthalmologic Biotherapeutics

...EIHENSTEPHAN, Germany, September 5 /PRNewswire/ -- pieris AG, a bio-pharmaceutical company developing Antica...n ophthalmologic disease. The studies reported by pieris relate to PRS-055, an Anticalin(R) specific for VE...s-ag.com Anticalin(R) is registered trademark of pieris AG. For further information, please contact: ...
Other Tags
(Date:4/24/2014)... Pa. (April 24, 2014) - Contact lenses coated with an ... lens-related infections, reports a study in Optometry and ... Academy of Optometry . The journal is published by ... Wolters Kluwer Health . , Studies in animals and now ... the antimicrobial peptide melimine, according to the new research by ...
(Date:4/24/2014)... before, during and after colorectal surgery cut hospital stays ... researchers who led a study of the approach at ... is easier on patients before surgery, doing away with ... prescribed. After surgery, patients are encouraged to eat and ... recoveries. , Among findings published in the May 2014 ...
(Date:4/24/2014)... new Institute for Biomedical Sciences at Georgia State ... grant to develop novel therapeutics against Respiratory Syncytial ... Eunice Kennedy Shriver National Institute Of Child Health ... Health will support Plemper,s drug development goals of ... distinct alternative compound. , Infections by RSV, a ...
(Date:4/24/2014)... the corresponding terminology, and the relevance of palliation ... publications on randomized controlled trials (RCTs). This is ... Institute for Quality and Efficiency in Health Care ... report. , Together with external experts, IQWiG analysed ... lung cancer, malignant melanoma, and pancreatic cancer. For ...
(Date:4/24/2014)... than one out of three survivors of critical ... The Lancet Respiratory Medicine , and the ... than mentally. , It is one of the ... functional outcomes of critical care survivors, according to ... Medicine, and it highlights a significant public health ...
Breaking Medicine News(10 mins):Health News:Study supports safety of antimicrobial peptide-coated contact lenses 2Health News:Study supports safety of antimicrobial peptide-coated contact lenses 3Health News:New approach for surgery patients cuts hospital stays and costs 2Health News:New approach for surgery patients cuts hospital stays and costs 3Health News:Palliation is rarely a topic in studies on advanced cancer 2Health News:Palliation is rarely a topic in studies on advanced cancer 3Health News:Vanderbilt study finds physical signs of depression common among ICU survivors 2Health News:Vanderbilt study finds physical signs of depression common among ICU survivors 3
(Date:4/23/2014)... of Toronto Scarborough research shows that male black widow ... a rare example of mate preference by male ... post-doc Emily MacLeod and Maydianne Andrade, a professor in ... field studies and the wild that males overwhelmingly chose ... male black widows can tell whether a potential mate ...
(Date:4/23/2014)... TX (4/23/14) -- Researchers have found evidence of ... factors that increase aggressive behavior in children, especially ... not all children exposed to prenatal smoking will ... will not," said Brian Boutwell, Assistant Professor at ... and senior author on the study. "One ...
(Date:4/23/2014)... today announced Sophie Martin of the University of Lausanne, ... Medal. The award acknowledges her work to understand the ... the cell. , Martin has been working for the ... the way in which the spatial organization of cells ... last 11 years, she has been using fission yeast, ...
Breaking Biology News(10 mins):Picky male black widow spiders prefer well-fed virgins 2Genetics risk, prenatal smoking may predict behavioral problems 2EMBO Gold Medal 2014 awarded to Sophie Martin 2
Other Contents